Comment by cyberax

> This story actually checks out, which is quite the condemnation of our American drug development system.

Oh yeah, "corporations", "end-stage capitalism", blah blah.

The reality is that 95+% of drug candidates fail the trials. And a lot of them only fail during the Phase-3 where the efficacy is tested. It's likely that large companies tried it in-house and found that it's either too toxic or is ineffective in-vivo.